Skip to main content
. Author manuscript; available in PMC: 2013 Mar 25.
Published in final edited form as: Clin Dermatol. 2012 May-Jun;30(3):311–322. doi: 10.1016/j.clindermatol.2011.08.017

Fig. 1.

Fig. 1

Scaffold abnormalities account for barrier abnormality in lamellar ichthyosis and loricrin keratoderma. Milder clinical phenotype in loricrin keratoderma correlates with compensatory cross-linking of other cornified envelope (CE) precursors. In contrast, CE is absent or defective throughout stratum corneum (SC) in transglutaminase 1-negative lamellar ichthyosis, correlating with a more severe phenotype.